The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $256,501 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Silicon Kidney LLC, a small disadvantaged business. The funding supports the development of an Intracorporeal Hemodialysis System (IHEMO) to address mortality disparities among rural and remote end-stage kidney disease patients. The key products and services to be delivered include: 1) Identifying a zeolite material with clinically acceptable urea adsorption capacity, and 2) Prototyping a zeolite-enabled external dialysate system for integration with an implanted hemocartridge. This innovative system aims to enable more rural and remote patients to perform home hemodialysis, reducing travel requirements and missed treatments to address the unacceptable mortality health disparity. The award period is from May 1, 2024, to April 30, 2025.
Generated 3/4/25, 8:24 AM